Abstract:Background: Recent studies show that the risk of cardiovascular disease (CVD) increases from a lower nadir of systolic blood pressure (SBP) in women than men, and increases thereafter at a greater rate. This has led to a suggestion that sex-based SBP thresholds are required. We aimed to investigate sex differences in the associations of SBP and incident atherosclerotic CVD in a large prospective cohort. Methods: 420,649 UK Biobank participants with no prior history of CVD were included. Age-adjusted sex-specific risks, relative risks (RRs) and risk differences (RDs) relating SBP to CVD were estimated using Poisson and Cox regression. Results: Over 13.2 years of follow-up there were 28,628 CVD events. CVD risks across BP levels showed a ?J-shape?, and were higher in men than women at all BP levels. The lowest risks were at SBP 100-<105 mmHg (events per 10,000 person-years [95%CI]: 15.6 [11.8-23.1]) and 110-<115 (47.2 [41.8-53.0]) among women and men, respectively. Compared with SBP 100-<110, sex-specific RRs at above 120 were higher in women than men, but RDs were higher in men than women at all levels of SBP. Furthermore, compared to men at 100-<110 (i.e. the men with least risk), risks in women were lower at all levels of SBP below 170. Conclusions CVD risk is lowest for women at a slightly lower SBP than men and RRs for CVD increase with SBP at a slightly steeper rate in women. However, both risks and RDs in women are never greater than in men. This evidence suggests that women should not have lower BP thresholds.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is: Should women be set a lower blood pressure target value than men? Specifically, the study aims to explore the gender differences in the association between blood pressure and atherosclerotic cardiovascular disease (CVD), and to evaluate whether these differences imply that women need a lower blood - pressure threshold to prevent cardiovascular diseases. ### Research Background Recent years' research has shown that women's risk of cardiovascular diseases starts to increase from a lower systolic blood pressure (SBP) level and then rises at a faster rate. This has led some scholars to propose that gender - based SBP thresholds may be required. To verify this hypothesis, this study utilized the large - scale prospective cohort data of the UK Biobank to investigate the gender differences between blood pressure and CVD events. ### Research Methods - **Research Subjects**: 420,649 UK Biobank participants without a previous history of cardiovascular diseases. - **Blood Pressure Measurement**: Use the Omron HEM - 7015IT digital sphygmomanometer to measure systolic blood pressure (SBP) and diastolic blood pressure (DBP) twice and take the average value. - **Primary Outcome**: The first - occurring atherosclerotic cardiovascular disease (CVD), including coronary heart disease (CHD) and stroke. - **Statistical Analysis**: Use the Poisson regression model and Cox proportional - hazards regression model to estimate the age - adjusted risk rate and relative risk (RR) respectively. ### Main Findings - **Risk Pattern**: The CVD risk is "J" - shaped distributed with the blood pressure level. Women have the lowest risk when SBP is 100 - <105 mmHg, and men have the lowest risk when SBP is 110 - <115 mmHg. - **Relative Risk**: Compared with the reference group, women have a higher relative risk (RR) when SBP is higher than 120 mmHg than men, but the risk difference (RD) is higher at all SBP levels. - **Common Reference Group Analysis**: When taking men's SBP 100 - <115 mmHg as the common reference group, women's risks at all SBP levels do not exceed men's, and only when SBP exceeds 170 mmHg, women's risk is slightly higher than men's. ### Conclusions - **Main Conclusion**: Although women's CVD risk starts to increase at a lower SBP level and then rises at a faster rate, overall, women's risks and risk differences never exceed men's. Therefore, the current evidence does not support that women need a lower blood - pressure threshold. - **Clinical Significance**: According to the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines, the threshold for antihypertensive treatment should be based on the calculation of absolute risk rather than the blood pressure level alone. At the same time, when evaluating gender differences, relative risk and risk difference should be considered comprehensively. ### Keywords Gender differences, Hypertension, Coronary heart disease, Stroke Through these research results, the author hopes to provide more accurate guidance for clinicians to better manage and prevent cardiovascular diseases.

Should women have lower blood pressure targets than men? Sex differences in blood pressure and cardiovascular disease in the UK Biobank